Bellicum Pharmaceuticals

Create an alert
to follow the executive moves at Bellicum Pharmaceuticals.

Most searched biographies at Bellicum Pharmaceuticals

• Rick Fair, President, Chief Executive Officer and Director
• Reid Huber, Director
• James Brown, Chairman of the Board

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).

Other contacts in the Pharmaceuticals industry

• Albert Bourla - Chief Executive Officer and Chairman of the Board at Pfizer
• Per-Olof Attinger - Executive Committee Secretary at Roche
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann

Learn more about the Pharmaceuticals industry >

Latest news about Bellicum Pharmaceuticals

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bellicum
Bellicum to Participate in Two Upcoming Virtual Conferences - Bellicum
Bellicum to Participate in Two Upcoming Virtual Investor Conferences - Bellicum
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bellicum
Bellicum Reports Second Quarter 2020 Financial Results and Provides Operational Update - Bellicum

Bellicum Pharmaceuticals on Wikipedia, Google News & Yahoo Finance

Bellicum Pharmaceuticals on LinkedIn, Twitter & YouTube

Bellicum Pharmaceuticals has 2,030 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland).

Contact by email its executives including Rick Fair

Call Bellicum Pharmaceuticals at +1 832....

View the org chart

Register to receive your alert

Report an error